Zobrazeno 1 - 10
of 110
pro vyhledávání: ''
Publikováno v:
Bioengineered
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 2, Pp 10891-10904 (2021)
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 2, Pp 10891-10904 (2021)
Clear cell renal cell carcinoma (ccRCC) is one of the most common malignant tumors worldwide. The clinical treatment of ccRCC is strongly associated with the tumor microenvironment (TME). Identifying potential markers of ccRCC is important to improve
Publikováno v:
Bioengineered
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 1, Pp 7941-7949 (2021)
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 1, Pp 7941-7949 (2021)
Hepatocellular carcinoma (HCC) is one of the most prevalent malignant neoplasms with high relapse and mortality rate. It is of great importance to identify novel and effective molecular markers to predict prognosis for the treatment of HCC. The Ewing
Publikováno v:
Bioengineered
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 1, Pp 7907-7919 (2021)
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 1, Pp 7907-7919 (2021)
Long non-coding RNA (lncRNA) CASC9 is reported to be a tumor promoter in oral cancer, but its mechanism in oral squamous cell carcinoma (OSCC) has not been fully explored. Our study aimed to identify the interaction between lncRNA CASC9, microRNA-545
Autor:
Surakameth Mahasirimongkol, Jiraphun Jittikoon, Wanvisa Udomsinprasert, Usa Chaikledkaew, Sittisak Honsawek, Sukanya Wattanapokayakit, Wasun Chantratita, Wanchaloem Sakuntasri
Publikováno v:
Emerging Microbes & Infections
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Despite being highly effective, anti-tuberculosis (TB) drugs often induce adverse liver injury, anti-TB drug-induced liver injury (ATDILI), leading to treatment failure given no sensitive and selective ATDILI markers. Herein, we conducted a case–co
Publikováno v:
Bioengineered
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 1, Pp 4856-4867 (2021)
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 1, Pp 4856-4867 (2021)
The effects of transmembrane protein 119 (TMEM119) on breast cancer progression have not been elucidated. This study aims to investigate the roles of TMEM119 in breast cancer progression. Clinical samples and online datasets were used to determine TM
Autor:
Li-Sheng Wang, Xuan-ming Chen, De-feng Li, Yu-ling Bin, Ben-Hua Wu, Xing-xing Long, Jun Yao, Hong-sai Hu, Mei-Feng Yang, Quan-zhou Peng
Publikováno v:
Bioengineered
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 1, Pp 3550-3565 (2021)
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 1, Pp 3550-3565 (2021)
Synaptotagmins (SYTs), constitute a family of 17 membrane-trafficking protein, palying crucial roles in the development and progression of human cancers. However, only very few studies have investigated the expression profile and prognostic values of
Publikováno v:
Cell Cycle
article-version (VoR) Version of Record
article-version (VoR) Version of Record
This study aimed to determine the mechanism underlying the regulation of gout by the HOX transcript antisense RNA (HOTAIR) long non-coding RNA (lncRNA). The expression levels of HOTAIR, miR-20b, and Nlrp3 were estimated by qRT-PCR and western blottin
Publikováno v:
Annals of Medicine
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Aim MicroRNA-21 is an oncogenic miRNA that modulates the expression of multiple cancer-related target genes. We conducted this meta-analysis to assess diagnostic role of circulating miR-21 in CRC, hoping to choose the best biomarker in CRC diagnosis.
Autor:
Sze Hong Law, Wing-cheong Chan, Hela Koka, Cherry Wu, Lap Ah Tse, Amy Hutchinson, Maeve Kiely, Xiaohong R. Yang, Feng Wang, Han Zhang, Belynda Hicks, Koon Ho Tsang, Difei Wang, Bin Zhu, Eric Karlins, Priscilla Ming Yi Lee
Publikováno v:
Epigenetics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Age-related DNA methylation is a potential mechanism contributing to breast cancer development. Studies of primarily Caucasian women have identified many CpG sites of age-related methylation in non-diseased breast tissue possibly driving cancer devel
Autor:
Caj Haglund, Kaisa Ahopelto, Jaana Hagström, Camilla Böckelman, Reetta Peltonen, Helena Isoniemi
Publikováno v:
Cancer Biology & Therapy
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Colorectal cancer (CRC) is the third most common cancer in the world. More than half of all affected patients develop liver metastases during the course of the disease, and over half experience recurrence despite radical primary surgery. Transketolas